Stemnovate Pulse - May 2023 Monthly Newsletter

"Life Science company of the year 2023"

Stemnovate was nominated for the 'Life Science Company of the Year' in the Science and Tech awards organized by Cambridge Independent.?

The other finalists were Astex Pharmaceuticals, Evonetix, Storm Therapeutics, source Bioscience and Cerevance.

Stemnovate provides commercial platforms for multi-species drug discovery. This is significant for reducing animal testing while ensuring the safety of human medicines.

The Cambridge Independent Science and Technology Awards 2023 was an incredible event celebrating the brightest minds in science and technology. The awards ceremony took place at Anglia Ruskin University in Cambridge.

Stemnovate features on BBC News

Our new production site is operational at the Cambourne business park. This site will be getting a new train station under the UK Government's East-West rail link, with funding of five Billion aiming to connect Oxford to Cambridge.

We had the chance to speak with BBC journalist Ben Schofield who came into the Cambourne office for a face-to-face interview with our CEO Ruchi Sharma about the impact of the new 'East-West Rail' and new stations at Tempsford and Cambourne.

Meetup at Cambridge

We hosted our monthly Meetup, Industrial Partnerships: A Way Forward To Clinical Translation, on Friday, 26th May, at The Grain and Hop Store in Cambridge. Partnerships help bring together great talents across academia and SMEs, and industry. We had the chance to meet and share our programs and opportunities.

Our partnerships are on Alzheimer's disease modelling, Hepatitis, Immune response and others on the mechanism of action for drug discovery.

New service launch: Karyometrix?

Stemnovate Ltd is rolling out a new database-based service platform Karyometrix. Here, you will have access to live interactive genomic data.

We have a digital karyotyping tool that screens and identifies structural chromosomal variations such as deletion, duplication, insertion and translocation changes on a genome-wide scale.

Our platform is at the cutting edge of the data revolution, and this platform will help us understand genetic and physiological pathways to diseases.

BioBeat23

We attended the BioBeat23 event. This annual event brings together entrepreneurs, investors, and academics to explore and discuss the latest trends and innovations in biotechnology.?

This year's event featured our CEO Ruchi Sharma, and a diverse range of speakers, including scientists, business leaders, and investors, who shared their insights and experiences in the field. Topics discussed included the latest advances in gene editing, personalized medicine, and the use of artificial intelligence in drug discovery.

Coming soon… BIO 2023

Keep an eye out as we are attending The BIO International Convention in Boston. This annual event brings together thousands of biotechnology leaders, investors, and policymakers from around the world to share ideas, network, and explore the latest trends and innovations in the field.